Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence

Current Rheumatology Reports

Volumn 17, Issue 10, 2015, Pages

  Ogdie, Alexis ^a,b   Gelfand, J M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Epidemiology; Psoriasis; Psoriatic arthritis; Risk factors

Indexed keywords

ALCOHOL CONSUMPTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; INCIDENCE; INFECTION; INJURY; NAIL DISEASE; OBESITY; PREVALENCE; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN MANIFESTATION; SMOKING; STRESS; ADVERSE EFFECTS; ARTHRITIS, PSORIATIC; COMPLICATION; DRINKING BEHAVIOR; EVIDENCE BASED MEDICINE; NAIL DISEASES; PROCEDURES;

ALCOHOL DRINKING; ARTHRITIS, PSORIATIC; EVIDENCE-BASED MEDICINE; HUMANS; NAIL DISEASES; OBESITY; PSORIASIS; RISK FACTORS; SMOKING;

EID: 84939634489     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-015-0540-1     Document Type: Review

References (42)

1. Kurd S, Gelfand J. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol. 2009;60(2):218–24.
2. Alamanos Y, Voulgari P, Drosos A. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol. 2008;35(7):1354–8.
3. Ibrahim G, Waxman R, Helliwell P. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum. 2009;61(10):1373–8.
4. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53(4):573.
5. Ogdie A, Langan S, Love T, et al. Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford). 2013;52(3):568–75.
6. Mease P, Gladman D, Papp K, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729–35.
7. Fitzgerald O, Haroon M, Giles JT, Winchester R. Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther. 2015;17(1):115. While our review discusses the clinical risk factors for PsA, this is an excellent review of the genetic risk factors for psoriatic arthritis and the interplay between genotypes and phenotypes in psoriatic arthritis.
8. Fletcher RH, Fletcher SW, Fletcher GS. Risk: basic principles. In: clinical epidemiology: the essentials. 5th ed. Baltimore: Lippincott Williams & Wilkins; 2014. p. 50–79.
9. Simon L. Pharmacovigilance: towards a better understanding of the benefit to risk ratio. Ann Rheum Dis. 2002;61(2):ii88–9.
10. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.
11. Ogdie A, Weiss PF. Epidemiology of Psoriatic Arthritis. Rheum Dis Clin North Am 2015; In Press.
12. Wu S, Han J, Qureshi AA. Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort study. Acta Derm Venereol. 2015;95(2):217–23.
13. Wu S, Li WQ, Han J, Sun Q, Qureshi AA. Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women. Arthrit Rheumatol. 2014;66(2):304–10. In this retrospective cohort study, Wu et al. found an increased incidence of both psoriasis and psoriatic arthritis among patients with physician-diagnosed hypercholesterolemia. In contrast, there was no association with cholesterol-lowering medications.
14. Tong LX, Wu S, Li T, Qureshi AA, Giovannucci EL, Cho E. Personal history of gallstones and risk of incident psoriasis and psoriatic arthritis in U.S. women. Br J Dermatol. 2015;172(5):1316–22.
15. Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013;72(5):736–40.
16. Gelfand J, Gladman D, Mease P, et al. Epidemiology of psoriatic arthritis in the population of the US. 2005; 53:573–7.
17. Wilson F, Icen M, Crowson C, McEvoy M, Gabriel S, Kremers H. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61(2):233–9.
18. Soltani-Arabshahi R, Wong B, Feng B, Goldgar D, Duffin K, Krueger G. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol. 2010;146(7):721–6.
19. Tey H, Ee H, Tan A, Theng T, Wong S, Khoo S. Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. J Dermatol. 2010;37(5):426–30.
20. Anandarajah A, Ritchlin C. Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol. 2004;16(4):338–43.
21. Ferrándiz C, Pujol RM, García-Patos V, Bordas X, Smandía JA. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol. 2002;46(6):867–73.
22. Stuart P, Malick F, Nair RP, et al. Analysis of phenotypic variation in psoriasis as a function of age at onset and family history. Arch Dermatol Res. 2002;294(5):207–13.
23. McGonagle D, Palmou Fontana N, Tan A, Benjamin M. Nailing down the genetic and immunological basis for psoriatic disease. Dermatology. 2010;221 Suppl 1:15–22.
24. Love T, Gudjonsson J, Valdimarsson H, Gudbjornsson B. Psoriatic arthritis and onycholysis—results from the cross-sectional Reykjavik psoriatic arthritis study. J Rheumatol. 2012;39(7):1441–4.
25. Scarpa R, Soscia E, Peluso R, et al. Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol. 2006;33(7):1315–9.
26. Thumboo J, Uramoto K, Shbeeb M, et al. Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol. 2002;29(4):757–62.
27. Thijssen E, van Caam A, van der Kraan P. Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue anddyslipidaemia in obesity-induced osteoarthritis. Rheumatology (Oxford). 2015;54(4):588–600.
28. Kumar S, Han J, Li T, Curhan G, Choi HK, Qureshi AA. Obesity, waist circumference, weight change, and the risk of psoriasis in US women. J Eur Acad Dermatol Venereol. 2013;27(10):1293–8.
29. Love T, Zhu Y, Zhang Y, et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis. 2012;71(8):1273–7.
30. Li W, Han J, Qureshi A. Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis. 2012;71(8):1267–772.
31. Ogdie A, Gelfand JM. Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need. Arch Dermatol. 2010;146(7):785–8.
32. Setty A, Curhan G, Choi H. Smoking and the risk of psoriasis in women: Nurses’ Health Study II. Am J Med. 2007;120(11):953–9.
33. Sugiyama D, Nishimura K, Tamaki K, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2010;69(1):70–81.
34. Eder L, Shanmugarajah S, Thavaneswaran A, et al. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis. 2012;71(2):219–24.
35. Eder L, Law T, Chandran V, et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken). 2011;63(8):1091–7.
36. Pattison E, Harrison B, Griffiths C, Silman A, Bruce I. Environmental risk factors for the development of psoriatic arthritis: results from a case–control study. Ann Rheum Dis. 2008;67(5):627–6.
37. Li W, Han J, Qureshi A. Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis. 2012;71(6):804–8.
38. Wu S, Cho E, Li WQ, Han J, Qureshi AA. Alcohol intake and risk of incident psoriatic arthritis in women. J Rheumatol. 2015;42(5):835–40.
39. Scott I, Tan R, Stahl D, Steer S, Lewis C, Cope A. The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013;52(5):856–67.
40. McGonagle D, Ash Z, Dickie L, McDermott M, Aydin S. The early phase of psoriatic arthritis. Ann Rheum Dis. 2011;70 Suppl 1:i71–6.
41. Manasson J, Scher J. Spondyloarthritis and the microbiome: new insights from an ancient hypothesis. Curr Rheumatol Rep. 2015;17(2):10. This review paper highlights the potential role of the microbiome (both the intestinal and skin microbiome) in the development of the spondyloarthropathies.
42. Eder L, Chandran V, Shen H. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care Res (Hoboken). 2011;63(4):619–22. Describes the first prospective longitudinal study to examine the incidence of PsA among patients with psoriasis.